{
  "drug_name": "Trimethobenzamide",
  "url": "https://wikem.org/wiki/Trimethobenzamide",
  "scraped_at": "2026-01-10T08:04:17.734043",
  "sections": {
    "Administration": {
      "text": "Type:\nAntiemetic\nDosage Forms: 200mg, 300mg\nRoutes of Administration: IM, PO\nCommon Trade Names: Tigan",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Antiemetic",
          "url": "https://wikem.org/wiki/Antiemetic"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "Nausea/Vomiting": {
          "text": "200mg IM q8h prn, 300mg PO q8h prn\nCan be used as an antiemetic in patients with a prolonged QTc",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Nausea/Vomiting": {
      "text": "200mg IM q8h prn, 300mg PO q8h prn\nCan be used as an antiemetic in patients with a prolonged QTc",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "",
      "subsections": {
        "Nausea/Vomiting_2": {
          "text": "Expert recommendations do\nnot\nsuggest trimethobenzamide as a therapeutic option; use has been replaced by newer agents with an improved safety profile",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Nausea/Vomiting_2": {
      "text": "Expert recommendations do\nnot\nsuggest trimethobenzamide as a therapeutic option; use has been replaced by newer agents with an improved safety profile",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "",
      "subsections": {
        "Renal_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Pregnancy_Rating": {
      "text": "",
      "subsections": {
        "Renal_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Lactation_risk": {
      "text": "",
      "subsections": {
        "Renal_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Renal_Dosing": {
      "text": "Adult:\nPediatric:",
      "subsections": {
        "Hepatic_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hepatic_Dosing": {
      "text": "Adult:\nPediatric:",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nHypersensitivity to trimethobenzamide or any component of the formulation\nUse in pediatric patients (injection only)",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 7 to 9 hours\nMetabolism: Via oxidation, forms metabolite trimethobenzamide N-oxide\nExcretion: Urine (30% to 50%, as unchanged drug)",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Acts centrally to inhibit the medullary chemoreceptor trigger zone by blocking emetic impulses to the vomiting center",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Comments": {
      "text": "No known QTc prolonging effects",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}